Axiisium Enrich · demonstration

Sequence the patients most likely to carry the marker.

Every candidate ranked by morphology-predicted likelihood of the trial's target marker, with the genes the model cannot see stated per patient. Sequencing still confirms enrollment. Known molecular status appears only to score the ranking, never as an input to it.

The signed record

Every prediction, state change and confirming assay in the production system is bound to a tamper-evident entry and linked to the one before it. This is that format, on a demonstration case.